PIERIS PHARMACEUTICALS, INC. (PIRS) Operating Income (Loss) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • Pieris Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$5.3 M, a 65.8% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$19.5 M, a 62.1% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$29.8 M, a 31.6% increase from 2022.
  • Pieris Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$43.5 M, a 16.1% increase from 2021.
  • Pieris Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$51.8 M, a 52.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$19.5 M -$5.3 M +$10.2 M +65.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$29.8 M -$4.5 M +$7.02 M +60.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$36.8 M -$11.8 M +$361 K +2.97% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$37.1 M $2.06 M +$14.4 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$51.5 M -$15.5 M -$8.05 M -108% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$43.5 M -$11.5 M -$520 K -4.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$43 M -$12.2 M +$6.84 M +36% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$49.8 M -$12.3 M +$4.43 M +26.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$54.2 M -$7.46 M -$2.4 M -47.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$51.8 M -$11 M +$1.41 M +11.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$53.2 M -$19 M -$6.01 M -46.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$47.2 M -$16.8 M -$12.1 M -260% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$35.1 M -$5.06 M -$1.2 M -31.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$33.9 M -$12.4 M -$11.1 M -833% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$22.8 M -$13 M -$10.1 M -346% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$12.8 M -$4.66 M +$7.58 M +61.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$20.3 M -$3.86 M +$6.83 M +63.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$27.2 M -$1.33 M +$11.3 M +89.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$38.5 M -$2.91 M +$4.89 M +62.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$43.4 M -$12.2 M -$9.99 M -445% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$33.4 M -$10.7 M -$2.55 M -31.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$30.8 M -$12.6 M -$19.1 M -295% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$11.7 M -$7.8 M -$2.62 M -50.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$9.08 M -$2.24 M +$5.65 M +71.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$14.7 M -$8.14 M -$130 K -1.62% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$14.6 M $6.49 M +$12.9 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$27.5 M -$5.18 M +$994 K +16.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$28.5 M -$7.89 M -$2.1 M -36.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$26.4 M -$8.01 M -$3.63 M -82.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$22.8 M -$6.4 M -$3.84 M -150% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$18.9 M -$6.18 M -$2.3 M -59.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$16.6 M -$5.8 M -$2.26 M -64% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$14.4 M -$4.38 M -$679 K -18.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$13.7 M -$2.57 M -$649 K -33.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$13 M -$3.88 M -$2.04 M -111% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$11 M -$3.53 M -$765 K -27.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$10.2 M -$3.7 M -$3.03 M -451% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$7.2 M -$1.92 M -$1.91 M -87071% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$5.28 M -$1.84 M -$1.84 M -31852% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$3.45 M -$2.77 M Apr 4, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$671 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$2.2 K* Oct 1, 2013 Dec 31, 2013 10-Q 2014-05-14
Q3 2013 -$5.76 K* Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.